Editorial: In vitro diagnosis of allergic and mast cell-mediated disorders

Joana Vitte; Alexandra F Santos

doi:10.3389/falgy.2024.1483398

Editorial: In vitro diagnosis of allergic and mast cell-mediated disorders

Front Allergy. 2024 Oct 25:5:1483398. doi: 10.3389/falgy.2024.1483398. eCollection 2024.

Authors

Joana Vitte^{1

2}, Alexandra F Santos^{3

4

5}

Affiliations

¹ Immunology Laboratory, Biology and Pathology Department, University Hospital of Reims, Reims, France.
² University of Reims Champagne Ardenne, INSERM UMR 1250, Reims, France.
³ Department of Women and Children's Health (Pediatric Allergy), Faculty of Life Sciences and Medicine, School of Life Course Sciences, King's College London, London, United Kingdom.
⁴ Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
⁵ Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom.

No abstract available

Keywords: COVID-19 vaccine; basophil activation test (BAT); component-resolved diagnosis (CRD); hereditary alpha-tryptasemia (HαT); immunoglobulin (Ig) E; in vitro diagnosis of allergy; mast cell (MC); molecular allergen.

Publication types

Editorial